Scott Davie

Title: Scott Davie - Innovator in Tumor Therapy Enhancement

Introduction

Scott Davie is a notable inventor based in Boulder, CO (US). He has made significant contributions to the field of medical technology, particularly in enhancing therapy uptake within tumors. His innovative approach aims to improve treatment outcomes for patients suffering from cancer.

Latest Patents

Scott Davie holds a patent for a method titled "Modulation of vascular adaptation within a tumor to increase therapy uptake within the tumor." This patent describes a system that utilizes a pressure-directed therapy approach. The system includes an infusion lumen, an occluder, and a pressure sensor to monitor the pressure distal to the occluder. By reducing the pressure in a target artery, the method allows for increased therapy infusion, which is carefully regulated based on vessel adaptation.

Career Highlights

Scott Davie is currently associated with Trisalus Life Sciences, Inc., where he continues to develop innovative solutions for cancer treatment. His work focuses on improving the efficacy of therapies through advanced medical technologies. With a patent portfolio that includes 1 patent, he is recognized for his contributions to the medical field.

Collaborations

Scott collaborates with talented professionals such as Trevor Mccaw and Michael Brick Markham. Their combined expertise fosters an environment of innovation and progress within their organization.

Conclusion

Scott Davie's work exemplifies the intersection of innovation and healthcare, showcasing how targeted therapies can be enhanced through advanced methodologies. His contributions are paving the way for improved cancer treatment strategies.